These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25480811)

  • 1. Gouty tophi: here today gone tomorrow.
    Mandokhel R; Pritchard G; Jones J
    Rheumatology (Oxford); 2015 Feb; 54(2):256. PubMed ID: 25480811
    [No Abstract]   [Full Text] [Related]  

  • 2. Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model.
    Jiang Y; Lin Y; Hu YJ; Song XJ; Pan HH; Zhang HJ
    BMC Complement Altern Med; 2017 Jun; 17(1):320. PubMed ID: 28623927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and Cure of Gouty Arthritis.
    Keller SF; Mandell BF
    Rheum Dis Clin North Am; 2022 May; 48(2):479-492. PubMed ID: 35400373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS; Huang W; Alton M; Maroli AN; Waltrip RW; Wright D; Marco MD
    J Clin Pharmacol; 2008 Jun; 48(6):708-18. PubMed ID: 18420531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More to rasburicase than uric Acid.
    Patel S; Le AN
    Pharmacotherapy; 2013 Sep; 33(9):e177. PubMed ID: 23744455
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.
    D Hayashi R; Yamaoka M; Nishizawa H; Fukuda S; Fujishima Y; Kimura T; Kozawa J; Kita S; Matsuoka TA; Otsuki M; Imagawa A; Ichida K; Taniguchi A; Maeda N; Funahashi T; Shimomura I
    Intern Med; 2017; 56(9):1071-1077. PubMed ID: 28458315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case presentation--tophaceous gout].
    Von Zingel M
    MMW Fortschr Med; 2012 Apr; 154 Suppl 1():8-9. PubMed ID: 23427363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperuricemia and gout : New aspects of an old disease].
    Witt M; Schulze-Koops H
    Internist (Berl); 2016 Jul; 57(7):656-65. PubMed ID: 27286837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
    Vines AN; Shanholtz CB; Thompson JL
    Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
    Fanouriakis A; Karantanas A; Fragouli E; Repa A; Sidiropoulos P
    Rheumatology (Oxford); 2014 Apr; 53(4):764-6. PubMed ID: 24185764
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis.
    Lemos Lima Rde C; Ferrari FC; de Souza MR; de Sá Pereira BM; de Paula CA; Saúde-Guimarães DA
    J Ethnopharmacol; 2015 Feb; 161():194-9. PubMed ID: 25500302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gout tophi and Heberden nodules in hyperuricemia].
    Peterseim U; von Gizycki-Nienhaus B; Schattenkirchner M; Meurer M
    Hautarzt; 1994 Nov; 45(11):799-802. PubMed ID: 7822208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegloticase-Associated Hemolysis.
    Minshar MA; Osman-Malik Y; Bhat ZY
    Am J Ther; 2019; 26(5):e622-e624. PubMed ID: 30211701
    [No Abstract]   [Full Text] [Related]  

  • 15. Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
    Herrington JD; Dinh BC
    J Oncol Pharm Pract; 2015 Apr; 21(2):111-7. PubMed ID: 24549060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author's reply: To PMID 23456733.
    McBride A
    Pharmacotherapy; 2013 Sep; 33(9):e177-8. PubMed ID: 24167830
    [No Abstract]   [Full Text] [Related]  

  • 17. Management and Cure of Gouty Arthritis.
    Keller SF; Mandell BF
    Med Clin North Am; 2021 Mar; 105(2):297-310. PubMed ID: 33589104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gouty arthritis].
    Yamanouchi T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():213-8. PubMed ID: 12629720
    [No Abstract]   [Full Text] [Related]  

  • 19. New urate depositions on dual-energy computed tomography in gouty arthritis during urate-lowering therapy.
    Zhang Z; Zhang X; Sun Y; Chen H; Kong X; Zhou J; Zhou Y; Ma L; Jiang L
    Rheumatol Int; 2017 Aug; 37(8):1365-1372. PubMed ID: 28447206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gouty arthritis in a 15-year-old girl with Bartter's syndrome.
    Derakhshan N; Derakhshan D; Basiratnia M; Fallahzadeh MH; Hashemi G; Derakhshan A
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1129-31. PubMed ID: 21060187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.